Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Aliment Pharmacol Ther. 2013 Sep;38(5):460-6. doi: 10.1111/apt.12417. Epub 2013 Jul 15.
The rate of exacerbation of inflammatory bowel disease (IBD) during pregnancy varies in the published literature.
We sought to perform a systematic review and meta-analysis of the effects of disease activity at conception on disease course during pregnancy in women with IBD.
Published studies and abstracts from standard sources were screened for appropriate studies. Data were pooled and analysed using funnel and forest plots. Quality assessment scores were given using GRADE criteria.
Fourteen studies were eligible for inclusion; ten studies contained patients with UC (N = 1130), and six studies contained patients with CD (N = 590). In patients with UC there was a significantly higher risk ratio of active disease during pregnancy in patients who commenced pregnancy with active disease (55%), when compared with those in remission at conception (36%) (RR 2.0, 95% CI: 1.5-3, P < 0.001). This risk was also higher in patients with CD (RR 2.0, 95% CI: 1.2-3.4, P = 0.006). Thirteen of the studies rated 'low' in all domains of a quality assessment, and there was significant statistical heterogeneity.
Patients with IBD who conceive when their disease is active are more likely to have active disease during pregnancy than those who conceive when in remission. All studies used in this analysis had a high risk of bias therefore further studies are required.
炎症性肠病(IBD)在怀孕期间恶化的发生率在已发表的文献中有所不同。
我们旨在对患有 IBD 的女性在受孕时疾病活动度对怀孕期间疾病进程的影响进行系统评价和荟萃分析。
筛选出合适的研究,对已发表的研究和标准来源的摘要进行筛选。使用漏斗图和森林图对数据进行汇总和分析。使用 GRADE 标准对质量评估评分进行评估。
有 14 项研究符合纳入标准;其中 10 项研究包含 UC 患者(N=1130),6 项研究包含 CD 患者(N=590)。在 UC 患者中,与受孕时处于缓解期的患者(36%)相比,起始妊娠时患有活动期疾病的患者在怀孕期间发生活动期疾病的风险比明显更高(55%)(RR 2.0,95%CI:1.5-3,P<0.001)。在 CD 患者中,这种风险也更高(RR 2.0,95%CI:1.2-3.4,P=0.006)。13 项研究在质量评估的所有领域均被评为“低”,且存在显著的统计学异质性。
患有 IBD 的患者,如果在疾病活跃时怀孕,那么在怀孕期间患有活动期疾病的可能性高于在缓解期怀孕的患者。本分析中使用的所有研究都存在高偏倚风险,因此需要进一步研究。